The University of Chicago Header Logo

Connection

Neval Ozkaya to Mutation

Back to Details
This is a "connection" page, showing publications Neval Ozkaya has written about Mutation.
Neval Ozkaya
Connection Strength
0.359
Mutation
  1. Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv. 2024 Nov 26; 8(22):5796-5805.
    View in: PubMed
    Score: 0.108
  2. Single-agent dabrafenib for BRAFV600E-mutated histiocytosis. Haematologica. 2018 04; 103(4):e177-e180.
    View in: PubMed
    Score: 0.068
  3. A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease. Nature. 2017 09 21; 549(7672):389-393.
    View in: PubMed
    Score: 0.065
  4. Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms. Hematol Oncol Clin North Am. 2017 08; 31(4):705-719.
    View in: PubMed
    Score: 0.064
  5. Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv. 2020 05 26; 4(10):2261-2271.
    View in: PubMed
    Score: 0.020
  6. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019 03; 567(7749):521-524.
    View in: PubMed
    Score: 0.018
  7. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood. 2017 07 13; 130(2):176-180.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.